Exelixis
EXEL
#1684
Rank
S$13.62 B
Marketcap
$47.73
Share price
1.61%
Change (1 day)
68.13%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company